Comparison of Adverse Events Among Home- vs Facility-Administered Biologic Infusions, 2007-2017.

ABSTRACT:

Importance

Infusion reactions occur in 7% to 20% of patients receiving biologics. Home infusions are convenient and incur lower costs but may be associated with more adverse events; the safety of receiving biologic infusions for immune-mediated diseases at home remains unclear.

Objective

To assess whether patients receiving home biologic infusions have increased adverse events requiring emergency department (ED) or hospital admission compared with patients receiving facility infusions.

Design, setting, and participants

This retrospective cohort study used administrative claims data from a large national insurer for adult patients who received biologic infusions for immune-mediated disease between January 2007 and December 2017. Patients with hematologic malignant neop

SUBMITTER: Baker MC 

PROVIDER: S-EPMC8176330 | biostudies-literature | 2021 Jun

REPOSITORIES: biostudies-literature